Logo image of MARP.MI

MARZOCCHI POMPE SPA (MARP.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:MARP - IT0004376858 - Common Stock

2.4 EUR
0 (0%)
Last: 11/3/2025, 7:00:00 PM
Fundamental Rating

3

Overall MARP gets a fundamental rating of 3 out of 10. We evaluated MARP against 102 industry peers in the Machinery industry. While MARP seems to be doing ok healthwise, there are quite some concerns on its profitability. MARP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year MARP has reported negative net income.
In the past year MARP had a positive cash flow from operations.
In the past 5 years MARP has always been profitable.
Each year in the past 5 years MARP had a positive operating cash flow.
MARP.MI Yearly Net Income VS EBIT VS OCF VS FCFMARP.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

MARP has a Return On Assets of -3.57%. This is amonst the worse of the industry: MARP underperforms 80.73% of its industry peers.
MARP's Return On Equity of -8.49% is on the low side compared to the rest of the industry. MARP is outperformed by 79.82% of its industry peers.
Industry RankSector Rank
ROA -3.57%
ROE -8.49%
ROIC N/A
ROA(3y)3.35%
ROA(5y)2.77%
ROE(3y)7.93%
ROE(5y)6.61%
ROIC(3y)N/A
ROIC(5y)N/A
MARP.MI Yearly ROA, ROE, ROICMARP.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

MARP's Profit Margin has improved in the last couple of years.
MARP's Operating Margin has declined in the last couple of years.
MARP has a better Gross Margin (47.39%) than 65.14% of its industry peers.
In the last couple of years the Gross Margin of MARP has remained more or less at the same level.
MARP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.39%
OM growth 3Y-25.57%
OM growth 5Y-1.68%
PM growth 3Y-40.58%
PM growth 5Y10.48%
GM growth 3Y-2.81%
GM growth 5Y-0.68%
MARP.MI Yearly Profit, Operating, Gross MarginsMARP.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

4

2. Health

2.1 Basic Checks

MARP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MARP has been reduced compared to 1 year ago.
MARP has less shares outstanding than it did 5 years ago.
The debt/assets ratio for MARP has been reduced compared to a year ago.
MARP.MI Yearly Shares OutstandingMARP.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
MARP.MI Yearly Total Debt VS Total AssetsMARP.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

MARP has an Altman-Z score of 1.63. This is a bad value and indicates that MARP is not financially healthy and even has some risk of bankruptcy.
MARP has a Altman-Z score of 1.63. This is comparable to the rest of the industry: MARP outperforms 41.28% of its industry peers.
MARP has a debt to FCF ratio of 12.11. This is a negative value and a sign of low solvency as MARP would need 12.11 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 12.11, MARP is doing worse than 68.81% of the companies in the same industry.
A Debt/Equity ratio of 0.15 indicates that MARP is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.15, MARP is in the better half of the industry, outperforming 74.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 12.11
Altman-Z 1.63
ROIC/WACCN/A
WACC7.31%
MARP.MI Yearly LT Debt VS Equity VS FCFMARP.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

MARP has a Current Ratio of 1.64. This is a normal value and indicates that MARP is financially healthy and should not expect problems in meeting its short term obligations.
MARP has a Current ratio (1.64) which is in line with its industry peers.
A Quick Ratio of 1.04 indicates that MARP should not have too much problems paying its short term obligations.
The Quick ratio of MARP (1.04) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.04
MARP.MI Yearly Current Assets VS Current LiabilitesMARP.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

1

3. Growth

3.1 Past

MARP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -180.12%.
The Earnings Per Share has been growing by 11.15% on average over the past years. This is quite good.
The Revenue for MARP has decreased by -18.93% in the past year. This is quite bad
The Revenue has been growing slightly by 0.01% on average over the past years.
EPS 1Y (TTM)-180.12%
EPS 3Y-40.36%
EPS 5Y11.15%
EPS Q2Q%-159.58%
Revenue 1Y (TTM)-18.93%
Revenue growth 3Y-0.41%
Revenue growth 5Y0.01%
Sales Q2Q%-15.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MARP.MI Yearly Revenue VS EstimatesMARP.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MARP.MI Yearly EPS VS EstimatesMARP.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.1 0.2 0.3 0.4

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MARP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MARP.MI Price Earnings VS Forward Price EarningsMARP.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

MARP's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. MARP is more expensive than 79.82% of the companies in the same industry.
MARP's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MARP is cheaper than 70.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.25
EV/EBITDA 26.68
MARP.MI Per share dataMARP.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

MARP has a Yearly Dividend Yield of 3.68%.
Compared to an average industry Dividend Yield of 2.49, MARP pays a better dividend. On top of this MARP pays more dividend than 89.91% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, MARP pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.68%

5.2 History

The dividend of MARP is nicely growing with an annual growth rate of 35.72%!
Dividend Growth(5Y)35.72%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The dividend of MARP is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP0%
EPS Next 2YN/A
EPS Next 3YN/A
MARP.MI Yearly Income VS Free CF VS DividendMARP.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

MARZOCCHI POMPE SPA

BIT:MARP (11/3/2025, 7:00:00 PM)

2.4

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.01%
Inst Owner ChangeN/A
Ins Owners4.7%
Ins Owner ChangeN/A
Market Cap15.70M
Revenue(TTM)36.59M
Net Income(TTM)-1.76M
Analysts82.86
Price Target8.67 (261.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.68%
Yearly Dividend0.2
Dividend Growth(5Y)35.72%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.43
P/FCF 11.25
P/OCF 3.76
P/B 0.76
P/tB 0.78
EV/EBITDA 26.68
EPS(TTM)-0.27
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.21
FCFY8.89%
OCF(TTM)0.64
OCFY26.63%
SpS5.6
BVpS3.17
TBVpS3.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.57%
ROE -8.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.39%
FCFM 3.81%
ROA(3y)3.35%
ROA(5y)2.77%
ROE(3y)7.93%
ROE(5y)6.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.23%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-25.57%
OM growth 5Y-1.68%
PM growth 3Y-40.58%
PM growth 5Y10.48%
GM growth 3Y-2.81%
GM growth 5Y-0.68%
F-Score3
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 12.11
Debt/EBITDA 3.05
Cap/Depr 119.95%
Cap/Sales 7.61%
Interest Coverage N/A
Cash Conversion 414.2%
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.04
Altman-Z 1.63
F-Score3
WACC7.31%
ROIC/WACCN/A
Cap/Depr(3y)89.71%
Cap/Depr(5y)66.19%
Cap/Sales(3y)6.79%
Cap/Sales(5y)5.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-180.12%
EPS 3Y-40.36%
EPS 5Y11.15%
EPS Q2Q%-159.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.93%
Revenue growth 3Y-0.41%
Revenue growth 5Y0.01%
Sales Q2Q%-15.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-141.92%
EBIT growth 3Y-25.88%
EBIT growth 5Y-1.67%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.52%
OCF growth 3Y-29.86%
OCF growth 5Y-17.53%

MARZOCCHI POMPE SPA / MARP.MI FAQ

What is the fundamental rating for MARP stock?

ChartMill assigns a fundamental rating of 3 / 10 to MARP.MI.


What is the valuation status of MARZOCCHI POMPE SPA (MARP.MI) stock?

ChartMill assigns a valuation rating of 1 / 10 to MARZOCCHI POMPE SPA (MARP.MI). This can be considered as Overvalued.


Can you provide the profitability details for MARZOCCHI POMPE SPA?

MARZOCCHI POMPE SPA (MARP.MI) has a profitability rating of 3 / 10.


How financially healthy is MARZOCCHI POMPE SPA?

The financial health rating of MARZOCCHI POMPE SPA (MARP.MI) is 4 / 10.